ADRENALINE

1|Page
CREATED BY;- JIGAR PRAJAPATI(NMMC)(LG HOSPITAL)

 THESE QUESTIONS OF OBSTETRICS & GYAENECOLOGY

WERE ASKED IN GUJARAT UNIVERSITY EXAMINATION
FROM YEAR 2006-2022

 THE QUESTIONS ARE ARRANGED BY THEIR TOPICS AND

SECTIONS

 SIGN(*) INDICATES THAT QUESTIONS WERE ASKED AS

 YEAR-I (PATTERN SHOWS EXAMINATION OF MAJOR

BATCH)

 YEAR-II(PATTERN SHOWS EXAMINATION OF MINOR

BATCH)

THANK YOU
BY,
JIGAR PRAJAPATI
MO:8238520773

2|Page
OBSTETRICS
(PAPER-I_)

3|Page
THE PLACENTA AND FETAL MEMBRANES
STRUCTURE & DEVELOPMENT OF PLACENTA. ROLE OF PLACENTA DURING
PREGNANCY.(2016-II*,2010-II*,2007-I*,2008-II*,2019-II*,2015-I)

FUNCTIONS OF PLACENTA(2014-I*)

FUNCTION OF AMNIOTIC FLUID(2021-II,2013-II,2008-I*,2009-I*)

UTERO PLACENTAL CIRCULATION(2007-II)

PLACENTAL CIRCULATION(2006-II*)

UMBILICAL CORD(2019-I)

PHYSIOLOGICAL CHANGES IN PREGNANCY

HEMODYNAMIC CHANGES IN PREGNANCY.MX CASE OF FULL-TERM
PREGNANCY WITH CONGESTIVE HEART FAILURE.(2018-II*,2015-II*)

CARDIOVASCULAR CHANGES PREGNANCY. MX SECOND STAGE OF LABOR WITH

HEART DISEASE(2017-II*,2021-I*)

CARDIOVASCULAR CHANGES IN PREGNANCY(2012-II,2009-I*)

PHYSIOLOGICAL CHANGES IN THYROID FUNCTION IN PREGNANACY.Mx OF

HYPOTHYROIDISM IN PREGNANCY(2019-I*)

FE METABOLISM. DIAGNOSIS AND TREATMENT OF PIH METABOLISM(2016-I*)

FE METABOLISM(2014-II*)

CARBOHYDRATE METABOLISM. COMPLICATION OF DIABETES COMPLICATING

PREGNANCY(2016-II*)

WEIGHT GAIN IN PREGNANCY(2013-II)

PHYSIOLOGICAL CHANGES IN PREGNANCY(2012-I*,2007-I*)

DIAGNOSIS OF PREGNANCY
DIAGNOSIS OF PREGNANCY(2020-II)

4|Page
DIAGNOSIS OF PREGNANCY IN 1st TRIMESTER(2008-II*,2009-II*)

FETAL SKULL AND MATERNAL PELVIS

PLANE OF LEAST PELVIC DIMENSION-CHANGES OCCURING AT PLANE(2010-II*)

FETAL SKULL(2020-II)

ANTENATAL CARE, PRECONCEPTIONAL COUNSELLING

& CARE
PROTOCOL FOR ANTENATAL VISITS AS PER WHO IN A NORMAL
PREGNANCY(2017-II)

AIMS & OBJECTIVES OF ANTENATAL CARE(2012-I)

DEFINE ANTENATAL CARE.WRITE ABOUT AIMS,OBJECTIVES OF ANTENATAL

CARE AND PROCEDURE AT FIRST ANTENATAL VISIT(2020-II*)

ANTENATAL COMPLICATIONS OF MULTIPLE PREGNANCY(2009-I)

PRE CONCEPTIONAL COUNSELLING AND CARE(2007-I*)

DIET DURING PREGNANACY(2008-II)

ANTENATAL ASSESSMENT OF FETAL WELLBEING

NON-STRESS TEST(2018-II,2012-I,2022-II)

BIOPHYSICAL PROFILE SCORE(2022-I,2013-II,2011-I,2010-II)

PRENATAL GENETIC COUNSELLING, SCREENING &

DIAGNOSIS
ANUEPLOIDY SCREENING(2019-I)

SCREENING OF DOWN’S SYNDROME(2017-I)

FEATURES OF DOWN SYNDROME IN NEW BORN(2021-I)

5|Page
 NORMAL LABOR
MECHANISM OF LABOR.STAGES OF LABOR AND Mx(2021-II*)

1ST STAGE OF NORMAL LABOR(2018-I,2009-II*)

MX OF 3rd STAGE OF LABOR(2018-II,2007-I)

ACTIVE MX OF 3rd STAGE OF LABOR(2016-II,2008-II,2019-I)

3RD STAGE OF LABOR(2013-I,2007-II*)

STAGES OF LABOR. MX 3rd STAGE OF LABOR(2014-I,2012-I)

MECHANISM OF NORMAL LABOR(2013-II*,2012-II*)

DEFINE MECHANISM OF LABOR. MECHANISM OF LABOR IN RIGHT OCCIPUT

ANTERIOR POSITION.(2013-II*,2012-II*)

DEFINE NORMAL LABOR. STAGES OF LABOR.PARTOGRAM.(2011-II*)

MECHANISM OF LABOR -LEFT OCCIPITO-ANTERIOR POSITION(2009-I*)

NORMAL PUERPERIUM
COLOSTRUM(2018-II

LOCHIA(2009-I)

PUERPERIUM-CHANGES(2010-II*)

VOMITING IN PREGNANCY
MX HYPEREMESIS GRAVIDARUM(2016-II,2007-II)

HYPEREMESIS GRAVIDARUM(2006-II,2008-I*,2022-II)

HEMORRHAGE IN EARLY PREGNANCY

CERVICAL INCOMPETENCE(2018-I,2006-II)

MX INCOMPETENT CERVICAL OS(2016-I)

CERVICAL ENCERCLAGE(2011-II)
6|Page
THREATENED ABORTION(2018-I)

DEFINE RECURRENT MISCARRIAGE, ETIOLOGY, INVESTIGATION & PRECAUTION

TO TAKEN AT TIME OF CESAREAN(2017-I*)

ETIOLOGY OF RECURRENT PREGNANCY LOSS (RPL)(2013-II)

RPL, ETIOLOGY, INVESTIGATION SEND IN RPL(2012-II*)

INCOMPLETE MISCARRIAGE MX (2017-II)

DEFINE ABORTION.TYPES OF ABORTION.CLINICAL FEATURES ,USG FINDINGS

AND TREATMENT OF INCOMPLETE ABORTION(2020-II*)

INCOMPLETE ABORTION(2012-II)

SEPTIC ABORTION(2016-I,2015-II)

FIRST TRIMESTER MTP(2016-I*)

MTP ACT(2014-I,2013-I)

MEDICAL TREATMENT OF ECTOPIC PREGNANCY (2016-I,2015-II,2015-I)

SURGICAL MANAGEMENT OF ECTOPIC PREGNANCY(2006-II)

EARLY UNRUPTURED ECTOPIC PREGNANCY(2013-I)

D/D OF 2 MONTHS AMENORRHEA & BLEEDING P/V(2014-I)

Mx OF MOLAR PREGNANCY(2006-II*)

DEFINE MOLAR PREGNANCY.Mx OF COMPLETE MOLE(2019-I*)

ECTOPIC PREGNANCY-PATHOLOGY(2007-II*)

MISSED ABORTION(2009-I)

RECURRENT SPONTANEOUS ABORTION(2008-II*)

VESICULAR MOLE(2007-II,2008-I)

SHIRODKAR’S ENCIRCLING(2009-II)

7|Page
MULTIPLE PREGNANCY, AMNIOTIC FLUID DISORDER,
ABNORMALITIES OF PLACENTA & CORD
CIRCUMVALLATE PLACENTA(2018-II)

MULTIPLE PREGNANCY COMPLICATIONS AND Mx(2021-II*)

MONOAMNIOTIC-MONOCHORIONIC TWIN ,MONOCHORIONIC TWINS(2017-

II,2016-I)

OLIGOHYDRAMNIOS(2016-I)

MX OF SECOND TWIN(2016-I)

COMPLICATIONS OF MULTIPLE PREGNANCY / MULTIPLE GESTATIONS(2016-

II,2015-I,2021-I,2007-I)

POLYHYDRAMNIOS(2016-I,2020-II,2010-II,2006-II)

TYPES, DIAGNOSIS & COMPLICATION OF TWIN PREGNANCY(2013-II*)

TWIN-TWIN TRANSFUSION SYNDROME (TTTS)(2012-II,2020-II)

ETIOLOGICAL FACTORS FOR MULTIPLE GESTATION. COMPLICATION OF TWIN

PREGNANCY(2012-I*,2008-I)

DIAGNOSIS OF TWIN PREGNANCY(2011-II)

HYPERTENSIVE DISORDERS IN PREGNANCY

ETIOLOGY AND PATHOGENESIS OF PRE-ECLAMPSIA.COMPLICATIONS OF
ECLAMPSIA. ETIOPATHOLOGY OF PRE-ECLAMPSIA (2017-II*,2015-II*)

ENUMERATE SEVERE FEATURES OF PRE ECLAMPSIA .DISCUSS EMERGENCY Mx

OF PRIMIGRAVIDA WITH 37 WEEKS OF PREGNANCY WITH ANTEPARTUM
ECLAMPSIA(2021-I*)

COMPLICATION OF PRE-ECLAMPSIA(2008-I,2016-II,2012-I)

INVESTIGATION IN PRE-ECLAMPSIA(2012-II,2011-II)

FE METABOLISM. DIAGNOSIS AND TREATMENT OF PIH(2016-I*)

8|Page
ECLAMPSIA.(2016-I*)

ECLAMPSIA & Mx(2013-I*)

Mx OF SEVERE PREECLAMPSIA IN PRIMIGRAVIDA AT 34 WEEKS OF

PREGNANCY(2022-II*)

MgSO4 IN ECLAMPSIA.(2014-II,2007-I,2022-I)

ANTI HYPERTEMSIVE IN PREGNANCY(2021-II)

MX CASE OF ECLAMPSIA.(2014-I,2011-I,2007-II)

PRE ECLAMPSIS SEVERE MANAGEMENT(2010-II)

ANTEPARTUM HEMORRHAGE
ANTEPARTUM HEMORRHAGE. ETIOLOGY APH. INVESTIGATE WOMEN WITH
APH. PRECAUTION TAKEN AT TIME OF CAESAREAN DELIVERY IN
PLACENTA(2018-I*)

CAUSES OF APH / DEFINE + CAUSES(2015-I,2011-II)

DEFINE ANTEPARTUM HAEMORRHAGE AND ENUMERATE ITS CAUSES .DISCUSS

EXPECTANT Mx OF APH IN G2P1A0 WUTH 28 WEEKS OF PREGNANCY(2021-I*)

TYPES OF APH.(2012-I)

MX OF APH AT 32 WEEKS OF GESTATION(2011-I)

CLINICAL FEATURES OF ABRUPTIO PLACENTAE(2015-II*)

SYMPTOMS, SIGNS & COMPLICATIONS OF ABRUPTIO PLACENTAE(2014-I)

MX PLACENTA PREVIA(2014-II*)

D/D & MX OF APH AT 32 WEEKS OF PREGNANCY(2013-II*)

ABRUTIO PLACENTA(2019-I)

APH. TYPES OF APH. MX OF PRIMIGRAVIDA WITH 34 WEEKS PREGNANCY WITH

ABRUPTIO PLACENTAE(2012-II*)

McAFEE JOHNSON REGIMEN(2022-II)

9|Page
MEDICAL & SURGICAL ILLNESS COMPLICATING
PREGNANCY
SCREENING OF GESTATIONAL DIABETES(2018-I,2014-II)

CARBOHYDRATE METABOLISM. COMPLICATION OF DIABETES COMPLICATING

PREGNANCY.(2016-II*)

GESTATIONAL DIABETES. DIAGNOSIS. PRINCIPLES OF MX.(2013-I*)

DIABETIC EMBRYOPATHY(2012-I,2009-I)

DIABETES MELLITUS EFFECT ON PREGNANACY(2007-II)

HEP-B IN PREGNANCY(2018-I)

HEMODYNAMIC CHANGES IN PREGNANCY.MX CASE OF FULL-TERM

PREGNANCY WITH CONGESTIVE HEART FAILURE.(2018-II)

HIV IN PREGNANCY(2017-I)

CARDIOVASCULAR CHANGES PREGNANCY. MX SECOND STAGE OF LABOR WITH

HEART DISEASE(2017-II*)

MITRAL STENOSIS Mx IN FULL TERM LABOR(2006-II)

HEART DISEASE IN LABOR -Mx(2009-I)

PHYSIOLOGICAL ANEMIA OF PREGNANCY.Mx OF DIMORPHIC ANAEMIA AT 20

WEEKS OF GESTATION(2019-I*)

IRON DEFICIENCY ANEMIA IN PREGNANCY.(2016-I,2012-II,2008-II)

COMPLICATIONS OF ANEMIA(2015-II)

ANEMIA IN PREGNANCY.(2015-I)

SEVERE ANEMIA IN PREGNANCY(2013-I)

DEFINE ANEMIA IN PREGNANCY. CAUSES.(2012-I)

ANEMIA IN PREGNANCY. MX OF SEVERE ANEMIA AT 36 WEEKS OF

PREGNANCY(2011-II,2008-II,2022-I*)

10 | P a g e
WHAT IS ANAEMIA.DESCRIBE TYPES OF ANAEMIA. Mx OF IRON DEFECIENCY
ANAEMIA IN PREGNANT WOMEN(2020-II*)

ACUTE RETENTION OF URINE IN EARLY PREGNANY(2014-I)

ASYMPTOMATIC BACTERIURIA.(2013-I)

PREVENTION OF PARENT TO CHILD TRANSMISSION-HIV(2008-I,2009-I)

PRETERM LABOR & BIRTH, PRETERM RUPTURE OF THE

MEMBRANE, POSTMATURITY, INTRAUTERINE FETAL DEATH
PROM, ETIOLOGY & MX AT 30 WEEKS GESTATIONAL(2018-I*)

PRETERM LABOR. CAUSES & Mx OF PTL AT 32 WEEKS(2022-I*,2018-I*,2018-

II*,2016-I*)

CAUSES OF FETAL GROWTH RESTRICYION(2021-I)

PRETERM LABOR(2017-I)

MX PRETERM LABOR(2015-I*,2020-II)

INTRAUTERINE DEATH OF FETUS CAUSES. MANAGEMENT OF TERM

PREGNANCY WITH IUFD.(2018-II*)

IUFD CAUSES(2014-II)

PREMATURE PRELABOR RUPTURE OF THE MEMBRANE(2016-I,2009-II)

OLIGOHYDRAMINOS(2019-I)

SPECIAL CASES
SCAR DEHISCENCE(2009-II)

COMPLICATED PREGNANCY
IMMUNE-HYDROPS & PATHOPHYSIO. ROLE OF MIDDLE CEREBRAL PEAK
SYSTOLIC VELOCITY FOR DETECTION OF FOETAL ANAEMIA.(2017-I*)

HYDROPS FETALIS(2015-II)

11 | P a g e
DIAGNOSIS OF INTRAUTERINE FETAL DEATH(2019-I)

OBESITY IN PREGNANCY(2015-I)

BENEFITS & RISKS OF VAGINAL BIRTH AFTER CESAREAN SECTION(2013-II)

CONTRACTED PELVIS
CLINICAL PELVIMETRY. TYPES OF PELVIS.(2016-II*)

TRIAL OF LABOR(2015-I)

ABNORMAL UTERINE ACTION

INCO-ORDINATED UTERINE ACTION(2015-I*)

BANDL’S RING(2013-I)

COMPLICATED LABOR:
MALPOSITION,MALPRESENTATION & CORD
PROLAPSE
DEEP TRANSVERSE ARREST(2018-II,2020-II,2008-I)

Mx AFTER COMING HEAD IN BREECH DELIVERY(2016-II,2019-I)

BURNS-MARSHALL TECHNIQUE(2016-I)

CAUSES OF BREECH PRESENTATION AND DIAGNOSIS AND Mx(2022-I*)

DIAGNOSIS & MX OF BREECH PRESENTATION AT 37 WEEKS.(2011-I*)

Mx OF UMBILICAL CORD PROLAPSE(2021-I)

INCOMPLETE BREECH AT 2ND STAGE LABOR- Mx(2007-I)

ASSISTED VAGINAL DELIVERY IN BREECH PRESENTATIONS AND ITS

COMPLICATIONS(2008-II)

DELIVERY OF HEAD IN BREECH PRESENTATIONS(2009-II)

ANTENATAL Mx OF BREECH PRESENTATION(2010-II)

12 | P a g e
EXTERNAL CEPHALIC VERSION(2007-II)

COMPLICATIONS OF TRANSVERSE LIE(2022-I)

PROLONGED LABOR, OBSTRUCTED LABOR, DYSTOCIA

CAUSED BY FETAL ANOMALIES
SHOULDER DYSTOCIA(2021-I,2018-II,2016-I,2015-I,2010-II)

CONJOINED TWINS(2018-II,2006-II)

COMPLICATIONS OF THIRD STAGE OF LABOR

ACUTE INVERSION OF UTERUS / INVERSION UTERUS(2018-I,2016-I,2017-I*)

PLACENTA ACCRETE(2017-I,2011-II,2022-II)

ATONIC POSTPARTUM HEMORRHAGE(2017-II,2016-I,2014-II)

MX ATONIC PPH(2013-II,2008-II)

PPH CAUSES AND AND Mx(2021-II*)

PPH. TYPES OF PPH. MX OF ATONIC PPH(2012-I*,2022-II*)

EXPECTANT Mx OF PLACENTA PREVIA(2020-II)

PREVENTION OF ATONIC PPH(2007-II)

MX PPH (2011-I*)

RETAINED PLACENTA(2017-II,2015-II,2007-II)

Mx OF RETAINED PLACENT(2022-I)

MANUAL REMOVAL OF PLACENTA (MRP).(2016-I)

INJURIES TO BIRTH CANAL

RUPTURE UTERUS(2017-I)

13 | P a g e
ABNORMALITIES OF THE PUERPERIUM
PUERPERAL/POSTPARTUM PSYCHOSIS(2018-I)

PUERPERAL PYREXIA(2017-I)

CAUSES PYREXIA(2016-II)

DEFINE & MX PUERPERAL PYREXIA(2015-I*,2007-I)

DEFINE PUERPERIUM & CHANGES OCCURING DURING PEURPERIUM(2010-II*)

DEEP VEIN THROMBOSIS(2008-I)

THE TERM NEWBORN INFANT

LACTATION(2020-II)

BREASTFEEDING (2016-I)

ADVANTAGES OF BREASTFEEDING(2014-II)

IMPORTANCE OF BREASTFEEDING(2011-II)

LOW BIRTH WEIGHT BABY

IUGR. ENUMERATE THE CAUSES. MX OF CASE AT 35 WEEKS OF GESTATION
WITH IUGR + DIAGNOSIS(2013-I*,2011-I*)

DISEASES OF THE FETUS & THE NEWBORN

RESPIRATORY DISTRESS SYNDROME(2022-I)

APGAR SCORE(2021-II,2017-II,2009-I)

HYPOGLYCEMIA IN NEW-BORN (IN SEIZURES)(2017-II)

MECONIUM ASPIRATION SYNDROME (MAS)(2015-II)

NEONATAL JAUNDICE(2022-II,2012-II,2009-II)

14 | P a g e
PHARMACOTHERAPEUTICS IN OBSTETRICS
HEMODYNAMIC CHANGES IN PREGNANCY MX CASE OF FULL-TERM
PREGNANCY WITH CONGESTIVE HEART FAILURE(2018-II*)

PROSTAGLANDINS IN OBSTETRICS.(2022-I,2015-II,2010-II,2014-I*)

MISOPROSTOL(2011-I)

OXYTOCICS IN PREGNANCY(2021-I)

BETAMIMETIC TOCOLYTIC AGENTS IN PRETERM LABOR(2013-II)

OXYTOCIN(2013-I)

INDUCTION OF LABOR
AUGMENTATION OF LABOUR(2018-I)

INDUCTION OF LABOR(2017-I)

INDUCTION OF LABOR: INDICATIONS & VARIOUS METHODS OF INDUCING

LABOR(2014-II*)

PARTOGRAPH(2022-II,2021-II,2015-II,2012-II,2007-I,2008-I)

PARTOGRAPH & ITS ROLE IN ROLE IN MX OF LABOR(2014-I*)

DEFINE NORMAL LABOR. STAGES OF LABOR. PARTOGRAPH(2011-II*)

POOR BISHOP’S SCORE(2013-I)

POSTTERM PREGNANCY(2019-I)

POPULATION DYNAMICS & CONTROL OF

CONCEPTION
COUNSELLING FOR CONTRACEPTION IN PRIMIPAROUS WOMEN(2014-II)

LACTATIONAL AMENORRHEA METHOD OF CONTRACEPTION(2011-I)

15 | P a g e
 OPERATIVE OBSTETRICS
INDICATIONS & CONTRAINDICATIONS OF FORCEPS DELIVERY(2022-I*,2009-
II,2010-II)

PREREQUSITES FOR FORCEPS APPLICATION(2022-II)

INDICATION & CONTRAINDICATIONS OF VENTOUSE DELIVERY(2021-II)

LOWER UTERINE SGMENT(2022-II)

EXTERNAL CEPHALIC VERSION(2018-II,2013-II)

INDICATIONS FOR CESAREAN SECTION(2016-II)

COMPLICATION OF LSCS(2011-II)

ADVANTAGES OF LSCS(2007-II)

EPISIOTOMY(2012-I,2011-I,2008-II)

SAFE MOTHERHOOD, EPIDEMIOLOGY OF OBSTETRICS

MMR. PRESENT MMR OF INDIA(2017-II)

DEFINE MMR.MENTION VARIOUS CAUSES & EFFECT TO REDUCE MMR(2022-

II*)

MATERNAL MORTALITY(2014-I)

SPECIAL TOPICS IN OBSTETRICS

MECHANISM & MANAGEMENT OF DIC IN PATIENT WITH ABRUPTIO
PLACENTAE.(2017-II*)

FETAL DISTRESS(2016-I,2014-I)

CURRENT TOPICS IN OBSTETRICS

PRECONCEPTION & PRENATAL DIAGNOSTIC TECHNIQUES (PC PNDT) ACT(2014-
II,2012-II)

16 | P a g e
 IMAGING IN OBSTETRICS
ROLE OF DOPPLER IN OBSTETRICS(2016-I,2015-I)

OBSTETRIC USG(2012-II,2011-II)

ROLE OF USG IN DIAGNOSIS OF FOETAL CONGENITAL ANOMALIES(2022-I)

ROLE OF USG IN I & II TRIMESTER OF PREGNANCY(2021-II)

MISC
CERVICAL RIGIDITY IN LABOR(2017-I)

CAUSES OF BREATHLESSNESS AT 34 WEEKS PREGNANCY. MANAGEMENT OF

ANYONE OF THEM DURING PREGNANCY AND LABOR(2016-I*)

CAUSES OF PERINATAL MORTALITY(2021-II,2016-II)

POST-PARTUM PERIOD. MX OF POST-PARTUM WOMEN(2011-II*)

USE OF STEM CELL THERAPIES(2021-II)

OUTLET FORCEPS.(2011-I)

17 | P a g e
GYNAECOLOGY
(PAPER II)

18 | P a g e
ANATOMY OF THE FEMALE PELVIC ORGANS
TRANSFORMATION ZONE(2018-II)

ANATOMY OF PERINEUM(2017-II)

UROGENITAL DIAPHRAGM(2016-I)

ANATOMY OF PELVIC URETER & ITS IMPORTANCE(2016-II,2007-II*,2006-II*)

BARTHOLIN’S GLAND(2013-I)

PELVIC URETER(2009-I*,2010-II*)

FALLOPIAN TUBE(2021-II)

BLOOD VESSELS, LYMPHATIC DRAINAGE & INNERVATION

OF PELVIC ORGAN
LYMPHATIC DRAINAGE OF CERVIX. IMPORTANCE OF SENTINEL NODE
SAMPLING. RADIOTHERAPY IN CA CERVIX(2016-I*)

BLOOD SUPPLY OF FEMALE PELVIC ORGAN(2016-I)

BLOOD SUPPLY OF UTERUS(2006-I*)

2019-ORGANS
DIFFERENT CONGENITAL MALFORMATIONS OF FEMALE GENITAL
ORGANS,PRESENTATION,DIAGNOSIS AND Mx(2022-I*)

CLASSIFY GENITAL TRACT MALFORMATION.Mx OF BICORNUATE

UTERUS(2019-I*)

ANOMALIES OF VAGINAL DEVELOPMENT(2016-I)

CONGENITAL MALFORMATION OF UTERUS(2010-II*)

CONGENITAL ELONGATION OF CERVIX(2019-I)

PUBERTY – NORMAL & ABNORMAL

PRECOCIOUS PUBERTY (2017-II)

19 | P a g e
PHYSIOLOGY OF PUBERTY & CAUSES OF PUBERTY MENORRHAGIA(2016-II*)

PUBERTY MENORRHAGIA(2014-I*,2021-I*)

DELAYED MENARCHE(2010-II)

MENOPAUSE
HRT FOR MENOPAUSE(2014-I,2011-I,2019-II)

DEFINE MENOPAUSE.Mx OF CLIMATERIC IN NATURAL MENOPAUSE(2019-I*)

SYMPTOMS OF MENOPAUSE & IT’S Mx(2013-II,2007-II*)

MENSTRUATION
NORMAL PHYSIOLOGY OF NORMAL MENSTRUATION(2017-II*,2008-I*,2009-I*)

PHYSIOLOGY OF OVULATION & ENUMERATE THE CAUSES OF INFERTILITY WITH

A NOTE ON OVULATION INDUCTION DRUGS(2016-II*,2009-I)

MENSTRUAL CYCLE(2014-II*)

OVULAION AND INDICATORS OF OVULATION(2019-I*)

ENDOMETRIUM IN MENSTRUAL CYCLE(2013-I*,2007-I*)

OVARIAN CYCLE(2007-II*)

EXAMINATION OF A GYNECOLOGICAL PATIENT & THE

DIAGNOSTIC PROCEDURE
CULDOCENTESIS(2017-I)

PAP SMEAR(2021-I,2015-I,2014-I,2012-I,2007-I*,2006-I,2008-I)

COLPOSCOPY(2012-II,2006-II)

VIA CERVIX(2020-II)

IMAGING TECHNIQUES, OTHER DIAGNOSTIC PROCEDURE &

LASER IN GYN.

20 | P a g e
DIAGNOSTIC LAPAROSCOPY(2014-I)

UTERINE ARTERY EMBOLIZATION(2012-I)

PELVIC INFECTION
CLINICAL FEATURES & MX OF GENITAL TB IN A FEMALE AGE 30YRS WITH
PRIMARY INFERTILITY(2018-II*)

CAUSES OF PID, DIAGNOSIS & Rx(2017-I*)

MEDICAL MX OF PID(2015-II)

SIGNS ,SYMPTOMS OF ACUTE PID(2021-II)

PID (2014-I)

CHRONIC PID(2012-II)

TUBERCULAR SALPINGITIS(2017-I)

GENITAL TUBERCULOSIS(2022-II,2015-II*)

SEXUALLY TRANSMITTED INFECTIONS

BACTERIAL VAGINOSIS(2021-I,2018-II,2011-I)

SYMPTOMATIC MX OF STD(2014-II*)

INFECTIONS OF THE INDIVIDUAL PELVIC ORGAN

ABNORMAL VAGINAL DISCHARGE(2022-I)

TRICHOMONIASIS / TRICHOMONAS VAGINITIS(2018-I,2016-I,2013-I,2011-

II,2008-I,2007-I)

CANDIDIASIS / MONILIAL VAGINITIS(2016-I,2013-II,2012-I,2009-II,2010-II)

BARTHOLIN’S ABSCESS(2016-I,2015-I)

TUBO-OVARIAN MASS(2016-I)

VULVO-VAGINITIS(2015-II*,2008-II)

21 | P a g e
DYSMENORRHEA & OTHER DISORDERS OF MENSTRUAL
CYCLE
PREMENSTRUAL SYNDROME(2017-II)

CONGESTIVE DYSMENORRHOEA(2011-II)

DYSMENORRHOEA(2011-I)

PRIMARY DYSMENORRHEA(2022-II)

CAUSES OF DYSMENORRHEA(2022-I)

CRYPTOMENORRHEA(2022-II,2007-I)

SPASMODIC DYSMENORRHEA(2008-I)

ABNORMAL UTERINE BLEEDING

PATHOPHYSIOLOGY OF AUB, ITS CLINICAL IMPACT &MX OF POST-
MENOPAUSAL BLEEDING(2018-I*,2019-II*)

OLIGOMENORRHEA(2017-I)

MENORRHAGIA(2016-I,2008-I*)

MEDICAL Mx OF MENORRAGIA(2019-I)

MEDICAL MX OF DUB(2015-II,2006-I,2010-II)

Mx OF DUB(2013-II*,2007-II,2008-II*)

DEFINE DUB. TYPES OF DUB. MX OF ANOVULATORY DUB(2012-I*)

ABNORMAL UTERINE BLEEDING(2015-I*,2021-I*)

METROPATHIA HEMORRHAGICA(2013-I,2012-II,2009-II)

DISPLACEMENT OF THE UTERUS

UTERO VAGINAL PROLAPSE ,DIAGNOSIS,COMPLICATIONS AND Mx(2022-I*)

22 | P a g e
PREVENTION OF GENITAL PROLAPSE(2018-II)

ETIOLOGY OF GENITAL PROLAPSE(2016-II,2007-II)

VAULT PROLAPSE(2017-II)

MANCHESTER REPAIR OPERATION(2016-I)

CHRONIC INVERSION AND Mx(2015-II,2019-II)

SUPPORT OF UTERUS(2022-II,2019-II*,2020-II,2015-I,2014-I,2009-II*,2013-
I*,2011-II*,2006-II*,2008-II*)

CONSERVATIVE SURGERIES FOR MX OF UTEROVAGINAL PROLAPSE IN

REPRODUCTIVE AGE(2014-II)

OPERATION MX OF PROLAPSE UTERUS(2011-I)

ENUMERATE TYPES & DEGREE OF UTERO-VAGINAL PROLAPSE, WRITE MX OF

NULLIPAROUS PROLAPSE(2021-I,2012-II*,2019-II*)

DECUBITUS ULCER(2011-II)

TYPES OF UTERO VAGINAL PROLAPSE(2009-I)

Mx OF CASE OF 2 DEGREE PROLAPSE IN 25 YEAR WOMEN(2007-I)

FOTHERGILL OPERATION(2010-II)

INFERTILITY
INTRACYTOPLASMIC SPERM INJECTION(2018-II)

CERVICAL MUCUS OF POOR QUALITY (2017-I)

INFREQUENT OVULATION(2017-I)

TUBAL PATENCY TESTS(2017-II,2013-I,2011-I)

OVARIAN FACTOR IN INFERTILITY(2007-I)

TUBAL FACTORS IN INFERTILITY(2007-II,2019-II)

LUTEAL PHASE DEFECT (2016-I)

23 | P a g e
PHYSIOLOGY OF OVULATION & ENUMERATE THE CAUSES OF INFERTILITY WITH
A NOTE ON OVULATION INDUCTION DRUGS(2016-II*)

SECONDARY INFERTILITY(2016-I)

CAUSES OF FEMALE INFERTILITY(2015-II,2012-I,2022-II*)

INTRAUTERINE INSEMINATION(2015-II)

METHOD OF OVULATION DETECTION(2014-II,2013-II,2006-I*,2008-I,2010-II)

EVALUATION OF MALE FACTOR IN PRIMARY INFERTILITY(2014-II)

NORMAL SEMEN REPORT(2013-II,2008-I,2009-I)

CAUSES OF AZOSPERMIA(2022-I)

ANOVULATION(2014-I*)

DEFINE FERTILITY. CAUSES IN FEMALE INFERTILITY. MX OF ANOVULATION IN

INFERTILITY(2012-II*)

DEFINE INFERTILITY.CAUSES INVESTIGATION FOR EVALUATION OF FEMALE

INFERTILITY(2021-II*)

ASSISTED REPRODUCTIVE TECHNOLOGY(2010-II,2022-I)

CLOMIPHINE CITRATE(2007-II,2008-II)

BENIGN LESIONS OF UTERUS

RED DEGENERATION(2018-II)

DEGENERATION CHANGES IN FIBROID UTERUS(2011-I*)

CAUSES OF MENORRHAGIA IN FIBROID UTERUS. NONSURGICAL MX OF

FIBROID UTERUS(2016-I*)

SUBMUCOUS FIBROID(2016-I*)

FIBRID-CLASSIFICATION ,DIAGNOSIS AND Mx(2022-II*)

SYMPTOMS OF FIBROID UTERUS(2015-II,2006-I)

CLINICAL PRESENTATION OF SUBMUCOUS FIBROID(2014-II)

24 | P a g e
SIGNS & SYMPTOMS IN FIBROID UTERUS(2011-II)

CLASSIFICATION,CLINICAL FEATURES, DIAGNOSIS & MX OF FIBROID OF

UTERUS(2021-II*,2013-II*,2020-II*)

MEDICAL MX OF FIBROID(2012-II,2020-II,2009-I,2019-II)

Mx OF CASE OF ANTERIOR WALL INTRAMURAL FIBROID OF 5 CM WITH

INFERTILITY (2006-II)

BENIGN NEOPLASMS OF THE OVARY

CAUSES OF PELVIC LUMP. DIAGNOSIS & RX OF DERMOID CYST AT 40YRS IN
MULTIPARA(2018-I*)

DERMOID CYST OF OVARY(2016-I*,2006-I,2009-II,2013-I,2011-II,2020-II)

DYSGERMINOMA(2018-II)

BRENNER’S TUMOUR(2016-I)

MEIG’S SYNDROME(2013-I)

ENDOMETRIOSIS & ADENOMYOSIS

ENDOMETRIOSIS(2018-I,2011-II)

TREATMENT OF ENDOMETRIOSIS(2022-I,2021-I*,2009-II)

COMPLICATIONS OF ENDOMETRIOSIS(2021-II)

DEFINE, TYPES, CAUSES & MEDICAL Mx(2017-I*,2012-II*)

PATHOGENESIS OF ENDOMETRIOSIS(2016-II*,2013-I)

CHOCOLATE CYST(2015-I,2012-I,2019-II)

PARA OVARIAN CYST(2019-I)

ADENOMYOSIS OF UTERUS(2021-I,2015-I)

DIAGNOSIS & MX OF ADENOMYOSIS(2013-II)

CAUSES OF INFERTILITY IN ENDOMETRIOSIS(2008-II)

25 | P a g e
 PREMALIGNANT LESIONS
CIN. CLASSIFICATION, CAUSES & MX OF CIN-2 LESION(2018-I*)

TYPES OF ENDOMETRIAL HYPERPLASIA. POST-MENOPAUSAL BLEEDING(2016-

I*)

HPV VACCINE FOR PREVENTION OF CA CERVIX(2021-I,2013-II)

WHITE LESIONS OF VULVA(2008-II*)

GENITAL MALIGNANCY
STAGING OF CARCINOMA CERVIX(2018-I,2016-II,2015-I*,2007-I)

STAGING OF CARCINOMA CERVIX AND Mx(2022-II*)

CAUSES OF POST-MENOPAUSAL BLEEDING PER VAGINA. MX OF CARCINOMA

CERVIX FIGO STAGE II B(2018-II*)

SCREENING TECHNIQUE FOR CARCINOMA CERVIX(2021-II,2017-I)

PATHOGENESIS OF CRCINOMA CERVIX(2007-II*,2008-I*)

STANDARD PROTOCOLS FOR CERVICAL CA SCREENING(2017-II)

SCREENING METHOD FOR EARLY DETECTION OF CA CERVIX(2014-II*,2010-II)

MEDICAL RX FOR PREVENTION OF CA CERVIX(2013-II)

FIGO STAGING OF CA. CERVIX(2012-I*,2011-I,200-I*)

DESCRIBE TRANSFORMATION ZONE FIGO STAGING OF CA. CERVIX(2019-II*)

LYMPHATIC DRAINAGE OF CERVIX. IMPORTANCE OF SENTINEL NODE

SAMPLING. RADIOTHERAPY IN CA CERVIX(2016-I)

CAUSES OF CA. CERVIX / ETIOLOGY FOR CA. CERVIX(2016-I*,2013-I*)

KRUKENBERG TUMOUR(2016-II)

PROGNOSTIC FACTOR IN ENDOMETRIAL CARCINOMA(2015-II)

DIAGNOSIS OF ENDOMETRIAL CANCER(2014-II)

26 | P a g e
EPITHELIAL OVARIAN TUMOUR(2015-I)

CLASSIFICATION OF OVARIAN TUMOUR(2011-II*)

DERMOID OVARIAN TUMOUR(2019-II)

GRANULOMA CELL TUMOUR OF OVARY(2007-II)

GRANULOSA CELL TUMOUR(2022-II)

TUMOUR MARKERS OF OVARIAN CANCER(2021-I)

VESICULAR MOLE / HYDATIDIFORM MOLE(2012-II)

SIGNS, SYMPTOMS & MX OF HYDATIDIFORM MOLE(2011-I)

CAUSES OF CARCINOMA BODY UTERUS(2006-I*)

VULVA INTRAEPITHELIAL NEOPLASIA(2019-I)

URINARY PROBLEMS IN GYNECOLOGY

STRESS INCONTINENCE(2014-I*,2019-II)

GENITOURINARY FISTULA
THREE SWAB TEST(2018-I)

VESICOVAGINAL FISTULA(2008-I)

ETIOLOGY OF VESICO VAGINAL FISTULA(2022-II)

DISORDER OF SEXUAL DEVELOPMENT

ANDROGEN INSENSITIVITY SYNDROME. MX OF PRIMARY AMENORRHEA IN 17
YEARS OLD GIRL.(2018-II*)

GONADAL DYSGENESIS(2017-I)

TURNER SYNDROME(2009-I)

AMENORRHEA
PREMATURE OVARIAN FAILURE(2018-I)

27 | P a g e
CAUSES OF AMENORRHEA(2022-I)

SECONDARY AMENORRHEA(2018-I,2008-II)

ANDROGEN INSENSITIVITY SYNDROME. MX OF PRIMARY AMENORRHEA IN 17

YEARS OLD GIRL(2018-II*)

PSYCHOGENIC AMENORRHEA(2017-I)

PCOS(2022-II,2020-II*)

PHATOPHYSIO OF POLYCYSTIC OVARIAN SYNDROME(2017-II*)

PRIMARY AMENORRHEA(2020-II,2015-I*,2011-I*)

CONTRACEPTION
METHODS OF HORMONAL CONTRACEPTION(2021-II*)

MIRENA LNG IUD(2021-II,2018-II,2016-I,2013-II)

COMPLICATIONS OF IUD(2017-II,2009-I)

NEWER IUCD(2009-II)

MECHANISM OF ACTION OF IUCD(2006-II)

POST-PARTUM IUCD (2016-I)

MISSED IUD(2012-I)

FEMALE CONDOM(2019-I)

FEMALE STERILIZATION(2016-II)

LAPAROSCOPIC TUBAL LIGATION(2016-I,2012-II,2006-II)

TYPES OF TUBAL LIGATION(2009-I)

SELECTION OF PATIENT FOR TUBECTOMY(2007-II)

DIFFERENT METHODS OF ABDOMINAL TUBAL LIGATION(2008-II,2006-I)

PREOPERATIVE PREPARATION & COMPLICATION OFLAPAROSCOPIC TUBAL

STERILIZATION OPERATION(2013-II*)

28 | P a g e
MINI PILL(2015-II,2007-I)

CONTRACEPTIVE ADVICE TO LACTATING MOTHER(2015-I)

EMERGENCY CONTRACEPTION(2020-II,2014-II,2012-II,2011-II,2010-II,2009-
I,2008-I)

MECHANISM OF ACTION OF ORAL CONTRACEPTIVE PILLS(2014-I)

CONTRAINDICATIONS OF ORAL CONTRACEPTIVE PILLS(2022-II,2011-II)

CONTRAINDICATIONS AND COMPLICATIONS OF COMBINED ORAL

CONTRACEPTIVES PILLS(2021-I)

LONG ACTING REVERSIBLE CONTRACEPTIVE(2019-II)

BENEFICIAL EFFECTS OF OC PILL(2006-I,2007-II)

INJECTABLE CONTRACEPTION(2011-I)

VASECTOMY(2009-II)

BASIC PRINCIPLES OF RADIATION THERAPY, CHEMOTHERAPY,

IMMUNOTHERAPY & GENE THERAPY IN GYNAECOLOGY

COMPLICATION OF RADIOTHERAPY(2018-II)

HORMONES IN GYNECOLOGICAL PRACTICE

PROGESTERONE(2013-I,2012-II)

HYPERPROLACTINEMIA(2021-II)

SPECIAL TOPICS
CAUSES OF PELVIC LUMP. DIAGNOSIS & RX OF DERMOID CYST AT 40YRS IN
MULTIPARA(2018-I*)

NIPPLE DISCHARGE(2018-I)

CAUSES OF POST-MENOPAUSAL BLEEDING PER VAGINA. MX OF CARCINOMA

CERVIX FIGO STAGE II B(2018-II*)

29 | P a g e
CAUSES OF POST-MENOPAUSAL BLEEDING(2015-II*)

TYPES OF ENDOMETRIAL HYPERPLASIA. POSTMENOPAUSAL BLEEDING(2016-I*)

MX OF POST-MENOPAUSAL WOMEN(2012-I*)

PATHOPHYSIO OF HIGH SERUM PROLACTIN LEVELS, ITS CLINICAL IMPACT &

Mx(2017-I*)

WHITE DISCHARGE THROUGH VAGINA(2015-I)

OPERATIVE GYNECOLOGY
MYOMECTOMY(2017-II)

INDICATIONS OD DILATIONA ND CURETTAGE(2022-I)

INDICATIONS FOR HYSTERECTOMY(2016-II,2008-II)

INDICATIONS OF ABDOMINAL HYSTERECTOMY(2021-II)

HYSTEROSALPINGOGRAPHY(2021-I,2014-II,2009-II)

SUCTION AND EVACUATION(2006-I)

ENDOSCOPIC SURGERY IN GYNECOLOGY

ENDOSCOPY(2012-I)

PRACTICAL GYNECOLOGY
RING PESSARY(2011-II)

MISC
UNRUPTURED ECTOPIC(2018-I)

ECTOPIC PREGNANCY(2017-II,2022-I*)

MEDICAL Mx OF ECTOPIC PREGNANCY(2020-II)

SYMPTOMS & SIGNS OF ECTOPIC PREGNANCY9(2014-I)

CONSERVATIVE MX IN ECTOPIC PREGNANCY(2012-I)

30 | P a g e
IMPERFORATE HYMEN(2016-II,2008-I)

MTP ACT(2021-II,2019-I)

COMPLICATION OF MTP(2016-II)

HEMATOCOLPOS(2016-I,2014-I)

MEDICAL ABORTION(2020-II,2011-I)

PROSTAGLANDIN IN MTP(2006-II)

POSCO ACT(2019-I)

SELF EXAMINATION OF BREAST AND BREAST AWARNESS INITIATIVE(2019-I)

TEST TO DETECT TUBAL PREGNANCY(2008-II)

ROLE OF RADIOTHERAPY IN GYAENECOLOGY(2022-I)

31 | P a g e